Show simple item record

Pharmacology and drug interactions of cannabinoids

dc.contributor.authorLandmark, Cecilie Johannessen
dc.contributor.authorUlrich, Brandl
dc.date.accessioned2020-02-25T09:01:40Z
dc.date.accessioned2020-02-26T14:31:27Z
dc.date.available2020-02-25T09:01:40Z
dc.date.available2020-02-26T14:31:27Z
dc.date.issued2020
dc.identifier.citationLandmark CJL, Ulrich. Pharmacology and drug interactions of cannabinoids. Epileptic disorders. 2020;22:516-522en
dc.identifier.issn1294-9361
dc.identifier.issn1294-9361
dc.identifier.urihttps://hdl.handle.net/10642/8183
dc.description.abstractCannabinoids include a variety of substances, of which cannabidiol (CBD) is the main substance investigated for the treatment of epilepsy, and this will be the focus in the present review. CBD preparations exist in various forms. There are significant differences in quality controlregardingcontentandreproducibilityforanapproveddrugversus herbal preparations. Cannabidiol has challenging pharmacological properties, and pharmaceutical and pharmacokinetic aspects will depend on the formulation or preparation of a certain product. This article will focus on the characteristics, pharmacokinetic challenges, and interactions of standardised CBD-containing drugs based on evidence from clinical and pharmacokinetic studies.en
dc.description.sponsorshipAn educational grant was provided by GW Pharma.en
dc.language.isoenen
dc.publisherWileyen
dc.relation.ispartofseriesEpileptic Disorders;Vol. 22, Supplement 1
dc.rightsThis work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.en
dc.rights.urihttps://creativecommons.org/licenses/by-sa/4.0/
dc.subjectCannabidiolen
dc.subjectEpilepsyen
dc.subjectTreatmentsen
dc.subjectPharmacologyen
dc.subjectInteractionsen
dc.subjectDravet syndromesen
dc.titlePharmacology and drug interactions of cannabinoidsen
dc.typeJournal articleen
dc.typePeer revieweden
dc.date.updated2020-02-25T09:01:40Z
dc.description.versionpublishedVersionen
dc.identifier.doihttps://dx.doi.org/10.1684/epd.2019.1123
dc.identifier.cristin1797139
dc.source.journalEpileptic disorders


Files in this item

Thumbnail
Name:
CJL+Brandl+CBD+PK+inetractons+ ...
Size:
1.674Mb
Format:
PDF
View/Open

This item appears in the following Collection(s)

Show simple item record

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Except where otherwise noted, this item's license is described as This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.